The Safety of Antirheumatic Drugs (11.02.2022)
Disease-modifying antirheumatic drugs | Download Table
LIST OF DMARDS USED TO TREAT RHEUMATOID ARTHRITIS | Download Table
Frontiers | The Therapeutic Landscape of Rheumatoid Arthritis: Current State and Future Directions
Does treatment strategy influence the ability to achieve and sustain DMARD-free remission in patients with RA? Results of an observational study comparing an intensified DAS-steered treatment strategy with treat to target in
Real-world treatment patterns of rheumatoid arthritis in Brazil: analysis of DATASUS national administrative claims data for pharmacoepidemiology studies (2010–2020) | Scientific Reports
Conventional disease-modifying anti-rheumatic drugs combined with Chinese Herbal Medicines for rheumatoid arthritis: A systematic review and meta-analysis - ScienceDirect
Treatment of Juvenile Idiopathic Arthritis | Pediatric Annals
Conventional disease‐modifying antirheumatic drugs to treat rheumatoid arthritis - Rath - 2011 - Drug Development Research - Wiley Online Library
Patient disposition. DMARD, disease-modifying antirheumatic drug; mITT,... | Download Scientific Diagram
Biomolecules | Free Full-Text | Biomarkers to Personalize the Treatment of Rheumatoid Arthritis: Focus on Autoantibodies and Pharmacogenetics
Facilitators and Barriers to Adherence in the Initiation Phase of Disease-modifying Antirheumatic Drug (DMARD) Use in Patients with Arthritis Who Recently Started Their First DMARD Treatment | The Journal of Rheumatology
Cureus | The Cost-Effectiveness of and Adherence to Disease-Modifying Antirheumatic Drug (DMARD) Therapy in Rheumatoid Arthritis Patients in a Tertiary Care Teaching Hospital in Uttarakhand, India | Article
Small Molecule DMARD Therapy and Its Position in RA Treatment | IntechOpen
Emerging Treatments for Rheumatoid Arthritis: Update | Consultant360
Anti-rheumatoid drugs advancements: New insights into the molecular treatment of rheumatoid arthritis - ScienceDirect
Disease-Modifying Antirheumatic Drug - an overview | ScienceDirect Topics
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update | Annals of the Rheumatic Diseases
Biologic and Targeted Synthetic DMARD Utilization in the United States: Adelphi Real World Disease Specific Programme for Rheumatoid Arthritis | Rheumatology and Therapy
Biomedicines | Free Full-Text | DNA Methylation Signatures of Response to Conventional Synthetic and Biologic Disease-Modifying Antirheumatic Drugs ( DMARDs) in Rheumatoid Arthritis
Disease-modifying antirheumatic drugs - ScienceDirect
